Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digoxin vs Ivabradine in HFrEF (DIVA-REF)
NCT02046044Phase 4Unknown
- Sponsor
- Kocaeli University
- Start
- Jan 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ivabradine in heart failure with reduced ejection fraction (HFrEF), sponsored by Kocaeli University. Status: unknown.
02
Drugs
ivabradine
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT02046044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046044.